Covaxin has demonstrated 77.8% effectiveness against symptomatic COVID-19 and 65.2% protection against the new Delta variant
According to sero-surveys, India has about 400 million children, of whom nearly 60% or 240 million have already developed antibodies
For final clearance, the recommendations have been sent to the Drugs Controller General of India (DCGI).
Australia had imposed very strict travel restrictions on people travelling in and out of the country
For ramping up production of Covaxin, Bharat Biotech has collaborated with Indian Immunologiclas and Hester Biosciences
The government's Vaccine Maitri programme to help the global supply of vaccines aims will increase the rate of production in October- December quarter
As per the latest supply forecast, 1.1 billion doses are expected to become available for delivery between September and the end of 2021
Modi also appreciated the tireless efforts of Covid warriors, including doctors, paramedical staff, Asha and anganwadi workers, and teachers
The new facility at Ankleshwar has a manufacturing capacity of more than 1 crore doses per month.
The manufacturer had announced in May that it would produce an additional 200 million doses of Covaxin at its subsidiary's Ankleshwar-based facility.